We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-13%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$46B
AUM Growth
-$5.82B
(-11%)
Cap. Flow
+$1.91B
Cap. Flow
% of AUM
4.16%
Top 10 Holdings %
Top 10 Hldgs %
16.37%
Holding
3,033
New
111
Increased
2,420
Reduced
427
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$127M |
| 2 |
Cigna
CI
|
+$54M |
| 3 |
CVS Health
CVS
|
+$38.8M |
| 4 |
Marathon Petroleum
MPC
|
+$28.9M |
| 5 |
Diamondback Energy
FANG
|
+$19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$124M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$100M |
| 3 |
PX
Praxair Inc
PX
|
+$80.2M |
| 4 |
COL
Rockwell Collins
COL
|
+$43.7M |
| 5 |
ANDV
Andeavor
ANDV
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.95% |
| 2 | Financials | 15.85% |
| 3 | Healthcare | 14.41% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Industrials | 10.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
Fate Therapeutics
FATE
$290M
| $1.02M | ﹤0.01% |
79,379
+35,315
| +80% | +$492K |
|
2002
Stock Yards Bancorp
SYBT
$2.61B
| $1.01M | ﹤0.01% |
30,956
+6,941
| +29% | +$221K |
|
2003
Koppers
KOP
$1.01B
| $1.01M | ﹤0.01% |
59,431
+9,792
| +20% | +$230K |
|
2004
UNIFI
UFI
$128M
| $1.01M | ﹤0.01% |
44,312
+8,091
| +22% | +$204K |
|
2005
Atkore
ATKR
$3.16B
| $1.01M | ﹤0.01% |
50,918
+15,196
| +43% | +$318K |
|
2006
Central Garden & Pet Co
CENT
$2.91B
| $1.01M | ﹤0.01% |
36,638
+6,572
| +22% | +$172K |
|
2007
Park Aerospace
PKE
$810M
| $1.01M | ﹤0.01% |
55,883
+9,538
| +21% | +$172K |
|
|
CSW
2008
CSW Industrials
CSW
$5.67B
| $1.01M | ﹤0.01% |
20,866
+6,577
| +46% | +$327K |
|
|
SIR
2009
DELISTED
SELECT INCOME REIT
SIR
| $1.01M | ﹤0.01% |
136,981
-24,840
| -15% | -$208K |
|
|
LDL
2010
DELISTED
Lydall, Inc.
LDL
| $1M | ﹤0.01% |
49,471
+8,261
| +20% | +$225K |
|
|
STFC
2011
DELISTED
State Auto Financial Corp
STFC
| $1M | ﹤0.01% |
29,521
+7,227
| +32% | +$236K |
|
|
ALDR
2012
DELISTED
Alder Biopharmaceuticals
ALDR
| $1M | ﹤0.01% |
97,762
+42,624
| +77% | +$546K |
|
2013
Amkor Technology
AMKR
$13.5B
| $1M | ﹤0.01% |
152,412
+43,291
| +40% | +$286K |
|
2014
Tronox
TROX
$1.11B
| $1M | ﹤0.01% |
128,596
+40,888
| +47% | +$430K |
|
2015
Stoneridge
SRI
$205M
| $999K | ﹤0.01% |
40,528
+11,682
| +40% | +$297K |
|
|
MAXR
2016
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $998K | ﹤0.01% |
83,470
+24,495
| +42% | +$498K |
|
2017
PJT Partners
PJT
$4.42B
| $995K | ﹤0.01% |
25,660
+8,474
| +49% | +$380K |
|
2018
Vericel Corp
VCEL
$2.29B
| $991K | ﹤0.01% |
56,958
+21,422
| +60% | +$320K |
|
|
WLH
2019
DELISTED
WILLIAM LYON HOMES
WLH
| $991K | ﹤0.01% |
92,746
+15,468
| +20% | +$198K |
|
|
HAYN
2020
DELISTED
Haynes International, Inc.
HAYN
| $989K | ﹤0.01% |
37,446
+6,448
| +21% | +$200K |
|
|
EBSB
2021
DELISTED
Meridian Bancorp, Inc.
EBSB
| $988K | ﹤0.01% |
69,029
+22,473
| +48% | +$354K |
|
2022
American Coastal Insurance
ACIC
$498M
| $985K | ﹤0.01% |
59,249
+10,589
| +22% | +$201K |
|
|
BOLD
2023
DELISTED
Audentes Therapeutics, Inc
BOLD
| $984K | ﹤0.01% |
46,150
+16,632
| +56% | +$429K |
|
2024
Novavax
NVAX
$1.27B
| $983K | ﹤0.01% |
26,711
+8,138
| +44% | +$315K |
|
2025
Hyster-Yale Materials Handling
HY
$662M
| $975K | ﹤0.01% |
15,732
+4,465
| +40% | +$278K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2018 Portfolio in Review
As of Q4 2018, RhumbLine Advisers held 3,033 positions worth $46B, down 11% from $51.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
RhumbLine Advisers deployed $1.91B of net new capital in Q4 2018, opening 111 new positions and adding to 2,420 existing holdings. Its largest new stake was Linde: 805,738 shares worth $126M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $30.2M trimmed.
- RhumbLine Advisers's largest Q4 2018 buy was Linde: 805,738 shares worth $126M.
- RhumbLine Advisers added most to Cigna in Q4 2018, an estimated $54M increase.
- RhumbLine Advisers's biggest Q4 2018 reduction was Apple, cutting an estimated $30.2M.
- RhumbLine Advisers fully exited Aetna Inc in Q4 2018, selling an estimated $124M.
- RhumbLine Advisers's ten largest holdings make up 16% of its $46B portfolio in Q4 2018.
- RhumbLine Advisers opened 111 new positions and closed 53 in Q4 2018.
- RhumbLine Advisers's portfolio value fell 11% quarter-over-quarter to $46B.
Based on RhumbLine Advisers's 13F filing for Q4 2018, filed 31 Jan 2019.